Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aquestive, Astrazeneca, Avenue, Checkpoint, Daiichi Sankyo, Disc, Eli Lilly, Eyepoint, Glyscend, Lipocine, Maat, Merck & Co., Mersana, Newamsterdam, Synthekine Takeda, Telavant, Tonix, Urogen.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abbvie, Alterity, Amytrx, Essex, Humacyte, Karyopharm, Merck & Co., Moderna, Newamsterdam, Nymox, Organicell, Oryzon, Pharmabcine, Viage.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Know Labs, Noctrix Health, Truvian.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Ascletis, Compass Pathways, Elevar, Epsilogen, Gilead Sciences, Hoth, Immuron, Intrommune, Mindbio, Moonlake Immunotherapeutics, Remegen, Stoke, Third Harmonic.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Antengene, Biocity, Biogen, Gannex, Highfield, Kintor, Recce, Sathgen, Telix, Triastek, Zai.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Access Vascular, Electrocore.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abbvie, Bavarian, Belite, Biomea, CG, Crescendo, Cybin, Dyadic, Eagle, Gilead, Horizon, Kodiak, Lineage, Panbela, Paxmedica, Recce, Sunho, Syndax, Tango.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: ADC, Elucida Oncology, Promontory, Tonix, Triastek.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Nalu Medical.